Editorial accountability
Corrections log
Every correction we've published since launch — what was wrong, what we changed, who reported it. We target a 7-day SLA from report to public update.
3d response What was wrong: We listed Midi Health starting price as $99/mo. Actual starting price had increased to $129/mo on 2026-04-01.
What we changed: Updated starting price field. Added "last priced" stamp showing 2026-05-13. Added price-history note in changelog.
Reported by: reader
3d response What was wrong: Cited pancreatitis rate as 0.3% citing a 2023 study. The cited study had been retracted in early 2025.
What we changed: Replaced citation with SURMOUNT-1 trial data showing 0.4-0.6% rate range. Note the older study retraction is now in the source footnote.
Reported by: clinician-advisor
2d response What was wrong: Listed Evernow as available in 48 states. They had paused service in Texas and Florida pending compounding pharmacy review.
What we changed: Reduced state count to 46. Added note: "Service paused in TX/FL pending 503A pharmacy partner re-certification."
Reported by: brand
2d response What was wrong: Stated Costco transdermal estradiol patch was $9/month. Actual price was $19/month for the 0.05mg dose, $9/month is only for 0.025mg.
What we changed: Updated table to show per-dose pricing. Added "dose affects price" note.
Reported by: reader
2d response What was wrong: Implied all PCOS patients should be screened for insulin resistance. Updated AACE/ACE guidelines clarify screening criteria depend on phenotype.
What we changed: Rewrote section to reflect 4 PCOS phenotypes (Rotterdam criteria) and which need IR screening. Added link to PCOS phenotype quiz.
Reported by: clinician-advisor
Found an error?
We rely on readers, clinicians, and brands to flag inaccuracies. Email the editorial team with the URL and the specific claim. We acknowledge within 48 hours and publish corrections within 7 days. Severity classification rubric is documented in our methodology.